L. Veronica Lee

720 total citations
13 papers, 503 citations indexed

About

L. Veronica Lee is a scholar working on Surgery, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Veronica Lee has authored 13 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Economics and Econometrics and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Veronica Lee's work include Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical Economics and Policy (9 papers). L. Veronica Lee is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Pharmaceutical Economics and Policy (9 papers). L. Veronica Lee collaborates with scholars based in United States, France and United Kingdom. L. Veronica Lee's co-authors include Eric D. Peterson, Salim S. Virani, Tracy Y. Wang, Ann Marie Návar, Anne C. Goldberg, Jennifer G. Robinson, Véronique L. Roger, Michael J. Louie, Shuang Li and Corey Bradley and has published in prestigious journals such as Circulation, Scientific Reports and The American Journal of Cardiology.

In The Last Decade

L. Veronica Lee

13 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Veronica Lee United States 11 373 261 112 91 54 13 503
Joseph Elassal United States 11 231 0.6× 154 0.6× 131 1.2× 77 0.8× 22 0.4× 16 456
Andrew Koren United States 12 368 1.0× 212 0.8× 200 1.8× 119 1.3× 26 0.5× 33 600
Laney K. Jones United States 15 326 0.9× 239 0.9× 79 0.7× 77 0.8× 57 1.1× 60 668
Jetty A. Overbeek Netherlands 14 115 0.3× 46 0.2× 94 0.8× 298 3.3× 26 0.5× 57 716
Lotte Kaasenbrood Netherlands 7 146 0.4× 84 0.3× 154 1.4× 63 0.7× 14 0.3× 9 320
L. Lalonde Canada 8 100 0.3× 145 0.6× 81 0.7× 29 0.3× 94 1.7× 12 394
John Corbelli United States 11 328 0.9× 75 0.3× 241 2.2× 118 1.3× 15 0.3× 29 535
Buthaina Ibrahim Italy 7 104 0.3× 40 0.2× 120 1.1× 81 0.9× 14 0.3× 13 363
Oscar Fernández Cantero Spain 6 99 0.3× 103 0.4× 45 0.4× 67 0.7× 11 0.2× 8 409
Anna Citarella Italy 10 95 0.3× 61 0.2× 45 0.4× 73 0.8× 33 0.6× 33 287

Countries citing papers authored by L. Veronica Lee

Since Specialization
Citations

This map shows the geographic impact of L. Veronica Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Veronica Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Veronica Lee more than expected).

Fields of papers citing papers by L. Veronica Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Veronica Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Veronica Lee. The network helps show where L. Veronica Lee may publish in the future.

Co-authorship network of co-authors of L. Veronica Lee

This figure shows the co-authorship network connecting the top 25 collaborators of L. Veronica Lee. A scholar is included among the top collaborators of L. Veronica Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Veronica Lee. L. Veronica Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Raal, Frederick J., Jaakko Tuomilehto, Andrei C. Spósito, et al.. (2019). Treatment effect of alirocumab according to age group, smoking status, and hypertension: Pooled analysis from 10 randomized ODYSSEY studies. Journal of clinical lipidology. 13(5). 735–743. 3 indexed citations
2.
Vallejo‐Vaz, Antonio J., Kausik K. Ray, Henry N. Ginsberg, et al.. (2019). Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control. Atherosclerosis. 288. 85–93. 19 indexed citations
3.
Lowenstern, Angela, Ann Marie Návar, Shuang Li, et al.. (2019). Association of Clinician Knowledge and Statin Beliefs With Statin Therapy Use and Lipid Levels (A Survey of US Practice in the PALM Registry). The American Journal of Cardiology. 123(7). 1011–1018. 18 indexed citations
4.
Bradley, Corey, Tracy Y. Wang, Shuang Li, et al.. (2019). Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM Registry. Journal of the American Heart Association. 8(7). e011765–e011765. 179 indexed citations
5.
Kereiakes, Dean J., Norman E. Lepor, Robert Gerber, et al.. (2018). Efficacy and safety of alirocumab in patients with or without prior coronary revascularization: Pooled analysis of eight ODYSSEY phase 3 trials. Atherosclerosis. 277. 211–218. 11 indexed citations
6.
Lowenstern, Angela, Shuang Li, Ann Marie Návar, et al.. (2018). Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry. American Heart Journal. 200. 118–124. 15 indexed citations
7.
Vallejo‐Vaz, Antonio J., Henry N. Ginsberg, Michael H. Davidson, et al.. (2018). Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. Journal of the American Heart Association. 7(18). e009221–e009221. 18 indexed citations
8.
Nanna, Michael G., Ann Marie Návar, Tracy Y. Wang, et al.. (2018). Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. Journal of the American Heart Association. 7(10). 62 indexed citations
9.
Lowenstern, Angela, Shuang Li, Ann Marie Návar, et al.. (2018). Measurement of Low‐Density Lipoprotein Cholesterol Levels in Primary and Secondary Prevention Patients: Insights From the PALM Registry. Journal of the American Heart Association. 7(18). 12 indexed citations
10.
Nanna, Michael G., Ann Marie Návar, Pearl Zakroysky, et al.. (2018). Association of Patient Perceptions of Cardiovascular Risk and Beliefs on Statin Drugs With Racial Differences in Statin Use. JAMA Cardiology. 3(8). 739–739. 85 indexed citations
11.
Catapano, Alberico L., L. Veronica Lee, Michael J. Louie, et al.. (2017). Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials. Scientific Reports. 7(1). 45788–45788. 13 indexed citations
12.
Návar, Ann Marie, Tracy Y. Wang, Shuang Li, et al.. (2017). Lipid management in contemporary community practice: Results from the Provider Assessment of Lipid Management (PALM) Registry. American Heart Journal. 193. 84–92. 66 indexed citations
13.
Kastelein, John J.P., Dean J. Kereiakes, Christopher P. Cannon, et al.. (2015). Abstract 17099: Additional LDL-C Reduction Achieved With Alirocumab Dose Increase on Background Statin. Circulation. 132(suppl_3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Elassal Breakdown of academic impact, for papers by Andrew Koren Breakdown of academic impact, for papers by Laney K. Jones Breakdown of academic impact, for papers by Jetty A. Overbeek Breakdown of academic impact, for papers by Lotte Kaasenbrood Breakdown of academic impact, for papers by L. Lalonde Breakdown of academic impact, for papers by John Corbelli Breakdown of academic impact, for papers by Buthaina Ibrahim Breakdown of academic impact, for papers by Oscar Fernández Cantero Breakdown of academic impact, for papers by Anna Citarella
Rankless by CCL
2026